The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer

BackgroundCirculating tumor DNA (ctDNA) levels and blood tumor mutation burden (bTMB) have a significant impact on the prognosis of tumor patients. However, their prognostic role in immune checkpoint inhibitors (ICIs) in cancer patients is still unclear.MethodsWe used the Review Manager software (ve...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Jiayan Wei, Jia Feng, Yiming Weng, Zexi Xu, Yao Jin, Peiwei Wang, Xue Cui, Peng Ruan, Ruijun Luo, Na Li, Min Peng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Subjects:	ctDNA bTMB immune checkpoint inhibitor prognosis biomarker meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.706910/full